Clinical trial · Observational
Vitaccess Real MG Registry
Vitaccess Real MG Registry: A Prospective International Observational Patient Registry in Myasthenia Gravis Linking Clinical and Patient-reported Data.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myasthenia Gravis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The Vitaccess Real MG Registry
- timeFrame
- 10 years
- description
- A patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life.
Secondary outcomes (15)
- measure
- Describe the demographic characteristics of patients
- timeFrame
- At baseline
- description
- EMR data reported by HCPs or captured via EMR aggregator ("Registration Form")
- measure
- Describe change in clinical trial participation of patients
- timeFrame
- At follow-up visits (every 6±1 months) for up to 10 years
- description
- EMR data reported by HCPs or captured via EMR aggregator ("Clinical Trial Participation Form")
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult (age ≥18 years) with a clinically-confirmed diagnosis of myasthenia gravis (MG). * Resident in one of the scope countries. * Access to a smartphone/tablet/computer/laptop * Willing and able to provide informed consent in their local language to take part in the study. Exclusion Criteria: * Participation in a clinical trial at the time of study enrolment.
References
Publications (0)
Data not yet available